drugset / Trial / NCT00737191

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

NCT00737191

RandomizedDouble-blindSupportive care

Summary

RATIONALE: Opioids lessen pain caused by cancer. It is not yet known whether opioids are more effective when given together with or without olanzapine in treating cancer pain. PURPOSE: This randomized clinical trial is studying opioids to see how well they work when given together with or without olanzapine in treating patients with moderate to severe cancer pain.

Timeline

Start
2008-08
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 2.5 mg Oral
Subject Olanzapine Small molecule 5 mg Oral